Catch pre-market movers with AI signals.
KRSA
Korsana (KRSA) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Korsana market cap is 1.54B and enterprise value is 1.53B.
Share Statistics
Korsana has 45.54M shares outstanding, with a free float of 211.04K.
Valuation Ratios
Korsana's PE ratio is -228.96, PB ratio is 301.88, and PS ratio is --, showing whether the stock looks expensive or cheap.
Liquidity
Korsana's current ratio is 0.82, quick ratio is 0.82, and cash ratio is 0.75, showing its short-term liquidity position.
Return on Capital
Korsana's ROE is -98.22%, ROA is -82.29%, and ROIC is -99.93%, showing its return on capital profile.
Profitability
Korsana gross margin is --, operating margin is --, and net margin is --.
Operating Efficiency
Korsana's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
Korsana's revenue is --, gross profit is --, net income is -6.71M, and EBITDA is -6.82M.
Balance Sheet
Korsana's total debt is 0, net debt is 0, total equity is 5.09M, and cash is 1.39M.
Cash Flow Statement
Korsana's operating cash flow is -4.45M, free cash flow is -4.52M, and CapEx is --.
Dividends & Yields
Korsana dividend yield is 0.00%, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Korsana's latest analyst rating is Buy, with an analyst target price of --.
Company Info
Biotech company developing therapies for neurodegenerative diseases
Per Share Metrics
Korsana's EPS is -8.68, book value per share is 8.37, and free cash flow per share is --.
